Based on the important parameters obtained from the multivariate analysis, we performed a Kaplan–Meier survival analysis of the effect of TET2 on TFS in ET patients and determined that TET2-mutated ET patients had poorer TFS rates (p = 0.008) (Figure 4). This evidence concerns the gene TET2 and essential thrombocythemia.